Science Explorer Interactive view Map

Altimmune (United States)

World rank, all time
#12,619
of 42,892
Rank in United States
#2,754
of 8,685
Research works
219
▼ 62% vs 2013–17
Citations
12k
55.8 per fractional work
Top-10% rate
24.5%
record average 16.5%
Open access
40%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.14× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.42× its world share, 0 worksImmunology and Micro…Neuroscience: 1.48× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.25× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.53× its world share, 0 worksChemistryComputer Science: 0.46× its world share, 0 worksComputer ScienceEngineering: 0.48× its world share, 0 worksEngineeringMedicine: 3.15× its world share, 3 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.2×. Every wedge is a field page.

Who are the top researchers at Altimmune (United States)?

Ranked on the composite score, Herren Wu, Ronald Herbst and Nazzareno Dimasi lead among researchers whose main affiliation is Altimmune (United States).

  1. 1 Herren Wu United States · #206,261 worldwide 271 citations · 19 works
  2. 2 Ronald Herbst United States · #387,793 worldwide 110 citations · 39 works
  3. 3 Nazzareno Dimasi United States · #521,282 worldwide 70 citations · 17 works
  4. 4 Néstor A. Molfino United States · #1,168,638 worldwide 28 citations · 89 works
All ranked researchers at Altimmune (United States)

Which keywords describe research at Altimmune (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Epidemiology, Biopharmaceuticals, Immunogenicity, Antibody Engineering and Fc Receptors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Monoclonal Antibodies34▲ 108×3 topics
  2. Epidemiology32▲ 3.6×46 topics
  3. Therapeutic Antibodies31▲ 108×2 topics
  4. Glycosylation28▲ 58×3 topics
  5. Biopharmaceuticals18▲ 123×3 topics
  6. Immunogenicity18▲ 158×2 topics
  7. Inflammation17▲ 3.2×32 topics
  8. Antibody Engineering16▲ 74×1 topic
  9. Fc Receptors16▲ 74×1 topic
  10. Recombinant Proteins15▲ 128×2 topics
  11. Protein Aggregation14▲ 83×1 topic
  12. Stability14▲ 34×1 topic
  13. Monoclonal Antibody11▲ 74×2 topics
  14. Vaccine Development11▲ 17×7 topics
  15. Cancer10▲ 3.4×23 topics
  16. Cell Culture9▲ 39×2 topics
  17. Mammalian Cells9▲ 105×1 topic
  18. Recombinant Protein9▲ 105×1 topic
  19. Pathogenesis9▲ 7.3×11 topics
  20. Human Metapneumovirus8▲ 85×1 topic
  21. Respiratory Syncytial Virus8▲ 85×1 topic
  22. Treatment8▲ 2.9×18 topics
  23. Cancer Immunotherapy7▲ 24×3 topics
  24. Immunity7▲ 9.3×8 topics
  25. Tumor Microenvironment6▲ 8.3×6 topics
  26. Immune Response6▲ 4.6×15 topics
  27. Autoantibodies6▲ 12×6 topics
  28. Vaccine6▲ 6.8×9 topics
  29. Cancer Therapy6▲ 4.2×13 topics
  30. Pandemic6▲ 5.6×3 topics
  31. Innate Immunity5▲ 7.0×8 topics
  32. Respiratory5▲ 25×2 topics
  33. Antigen Presentation4▲ 20×2 topics
  34. Asthma4▲ 16×3 topics
  35. Virus4▲ 17×2 topics
  36. Antibodies4▲ 21×2 topics
  37. Dendritic Cells4▲ 17×2 topics
  38. Allergic Diseases4▲ 23×1 topic
  39. Bayesian Methods4▲ 32×2 topics
  40. Eosinophils4▲ 23×1 topic

Which research topics does Altimmune (United States) publish most on?

By volume in 2022–2025: Liver Disease Diagnosis and Treatment, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and CAR-T cell therapy research.

  1. 1 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  2. 2 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  3. 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  6. 6 Nanowire Synthesis and Applications Biomedical Engineering 0 works
  7. 7 Receptor Mechanisms and Signaling Molecular Biology 0 works
  8. 8 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  9. 9 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  10. 10 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.7%not open60.3%

World: 28% of research is openly available.

with international co-authors20.7%domestic only79.3%

World: 19% is written across borders.

How has Altimmune (United States)'s research output changed?

Output in 2018–2022 was 62% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.